NO316174B1 - Fremgangsmåte for syntese av nukleosid-analoger og mellomprodukter - Google Patents
Fremgangsmåte for syntese av nukleosid-analoger og mellomprodukter Download PDFInfo
- Publication number
- NO316174B1 NO316174B1 NO19974512A NO974512A NO316174B1 NO 316174 B1 NO316174 B1 NO 316174B1 NO 19974512 A NO19974512 A NO 19974512A NO 974512 A NO974512 A NO 974512A NO 316174 B1 NO316174 B1 NO 316174B1
- Authority
- NO
- Norway
- Prior art keywords
- compound
- ethoxy
- formula
- oxathiolan
- fluoro
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 27
- 239000002777 nucleoside Substances 0.000 title abstract description 7
- 239000000543 intermediate Substances 0.000 title abstract description 6
- 230000015572 biosynthetic process Effects 0.000 title description 3
- 238000003786 synthesis reaction Methods 0.000 title description 2
- 150000003833 nucleoside derivatives Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 42
- 239000000203 mixture Substances 0.000 claims description 35
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 229910052739 hydrogen Inorganic materials 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 229910052736 halogen Inorganic materials 0.000 claims description 10
- 150000002367 halogens Chemical class 0.000 claims description 10
- -1 hydroxy, amino Chemical group 0.000 claims description 10
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 claims description 10
- 239000002841 Lewis acid Substances 0.000 claims description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
- 239000001257 hydrogen Substances 0.000 claims description 9
- 150000002431 hydrogen Chemical group 0.000 claims description 9
- 150000007517 lewis acids Chemical class 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000001677 (2R,5R)-1,4-dithiane-2,5-diol Substances 0.000 claims description 4
- YUIOPHXTILULQC-UHFFFAOYSA-N 1,4-Dithiane-2,5-diol Chemical compound OC1CSC(O)CS1 YUIOPHXTILULQC-UHFFFAOYSA-N 0.000 claims description 4
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 238000002425 crystallisation Methods 0.000 claims description 4
- 230000008025 crystallization Effects 0.000 claims description 4
- 150000007530 organic bases Chemical class 0.000 claims description 4
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 claims description 3
- 239000000010 aprotic solvent Substances 0.000 claims description 3
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 claims description 3
- 230000001629 suppression Effects 0.000 claims description 3
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 claims description 3
- DLNKOYKMWOXYQA-VXNVDRBHSA-N (+)-norephedrine Chemical compound C[C@@H](N)[C@@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-VXNVDRBHSA-N 0.000 claims description 2
- 125000002252 acyl group Chemical group 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- DLNKOYKMWOXYQA-CBAPKCEASA-N (-)-norephedrine Chemical compound C[C@H](N)[C@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-CBAPKCEASA-N 0.000 claims 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- YKYIFUROKBDHCY-ONEGZZNKSA-N (e)-4-ethoxy-1,1,1-trifluorobut-3-en-2-one Chemical group CCO\C=C\C(=O)C(F)(F)F YKYIFUROKBDHCY-ONEGZZNKSA-N 0.000 claims 1
- FJKYFKBZMRPFGI-UHFFFAOYSA-N 2-(2,2-dimethoxyethoxy)-4-ethoxy-5-fluoropyrimidine Chemical group CCOC1=NC(OCC(OC)OC)=NC=C1F FJKYFKBZMRPFGI-UHFFFAOYSA-N 0.000 claims 1
- NLFRDKMWZHMSFP-UHFFFAOYSA-N 2-(4-ethoxy-5-fluoropyrimidin-2-yl)oxyacetaldehyde Chemical group CCOC1=NC(OCC=O)=NC=C1F NLFRDKMWZHMSFP-UHFFFAOYSA-N 0.000 claims 1
- NOMSWCCJZPAACH-UHFFFAOYSA-N [2-[(4-ethoxypyrimidin-2-yl)oxymethyl]-1,3-oxathiolan-5-yl] acetate Chemical compound CCOC1=CC=NC(OCC2SCC(O2)OC(C)=O)=N1 NOMSWCCJZPAACH-UHFFFAOYSA-N 0.000 claims 1
- 238000001212 derivatisation Methods 0.000 claims 1
- 239000003880 polar aprotic solvent Substances 0.000 claims 1
- VTGOHKSTWXHQJK-UHFFFAOYSA-N pyrimidin-2-ol Chemical compound OC1=NC=CC=N1 VTGOHKSTWXHQJK-UHFFFAOYSA-N 0.000 claims 1
- SYRHIZPPCHMRIT-UHFFFAOYSA-N tin(4+) Chemical compound [Sn+4] SYRHIZPPCHMRIT-UHFFFAOYSA-N 0.000 claims 1
- FTVLMFQEYACZNP-UHFFFAOYSA-N trimethylsilyl trifluoromethanesulfonate Chemical compound C[Si](C)(C)OS(=O)(=O)C(F)(F)F FTVLMFQEYACZNP-UHFFFAOYSA-N 0.000 claims 1
- 230000000840 anti-viral effect Effects 0.000 abstract description 4
- UDVWSTBKKYWADN-UHFFFAOYSA-N 4-ethoxypyrimidine Chemical class CCOC1=CC=NC=N1 UDVWSTBKKYWADN-UHFFFAOYSA-N 0.000 abstract 1
- 239000000047 product Substances 0.000 description 37
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 22
- 238000005481 NMR spectroscopy Methods 0.000 description 22
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 22
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 18
- 239000002904 solvent Substances 0.000 description 17
- 239000000243 solution Substances 0.000 description 16
- 239000007787 solid Substances 0.000 description 12
- 239000008346 aqueous phase Substances 0.000 description 11
- 235000019439 ethyl acetate Nutrition 0.000 description 11
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 150000002148 esters Chemical class 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 239000012074 organic phase Substances 0.000 description 8
- 239000000460 chlorine Substances 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000004587 chromatography analysis Methods 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 229920006395 saturated elastomer Polymers 0.000 description 6
- 239000007832 Na2SO4 Substances 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- 239000012299 nitrogen atmosphere Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 229910052938 sodium sulfate Inorganic materials 0.000 description 5
- 235000011152 sodium sulphate Nutrition 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 4
- 229910000831 Steel Inorganic materials 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 239000012267 brine Substances 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- 239000012230 colorless oil Substances 0.000 description 4
- 239000011737 fluorine Substances 0.000 description 4
- 229910052731 fluorine Inorganic materials 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
- 239000010959 steel Substances 0.000 description 4
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 3
- 108090000371 Esterases Proteins 0.000 description 3
- 239000004809 Teflon Substances 0.000 description 3
- 229920006362 Teflon® Polymers 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 230000013595 glycosylation Effects 0.000 description 3
- 238000006206 glycosylation reaction Methods 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 3
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 3
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- NYPNCQTUZYWFGG-UHFFFAOYSA-N 2,2-dimethoxyethanol Chemical compound COC(CO)OC NYPNCQTUZYWFGG-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- YHASWHZGWUONAO-UHFFFAOYSA-N butanoyl butanoate Chemical compound CCCC(=O)OC(=O)CCC YHASWHZGWUONAO-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229960002949 fluorouracil Drugs 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 229940127073 nucleoside analogue Drugs 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- WJJSZTJGFCFNKI-UHFFFAOYSA-N 1,3-oxathiolane Chemical compound C1CSCO1 WJJSZTJGFCFNKI-UHFFFAOYSA-N 0.000 description 1
- SIPSOOMVWYSLRP-UHFFFAOYSA-N 1,3-oxathiolane;pyrimidine Chemical compound C1CSCO1.C1=CN=CN=C1 SIPSOOMVWYSLRP-UHFFFAOYSA-N 0.000 description 1
- RQEUFEKYXDPUSK-UHFFFAOYSA-N 1-phenylethylamine Chemical compound CC(N)C1=CC=CC=C1 RQEUFEKYXDPUSK-UHFFFAOYSA-N 0.000 description 1
- HRPOUYCSSTWMEQ-UHFFFAOYSA-N 2-chloro-4-ethoxy-5-fluoropyrimidine Chemical compound CCOC1=NC(Cl)=NC=C1F HRPOUYCSSTWMEQ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- YBPDNNKTCJHWCS-WCQYABFASA-N [(2r,5s)-5-(4-ethoxy-2-oxopyrimidin-1-yl)-1,3-oxathiolan-2-yl]methyl butanoate Chemical compound C1S[C@H](COC(=O)CCC)O[C@@H]1N1C(=O)N=C(OCC)C=C1 YBPDNNKTCJHWCS-WCQYABFASA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical class O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000002243 furanoses Chemical class 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002718 pyrimidine nucleoside Substances 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9506644.5A GB9506644D0 (en) | 1995-03-31 | 1995-03-31 | Preparation of nucleoside analogues |
PCT/EP1996/001353 WO1996030369A1 (en) | 1995-03-31 | 1996-03-26 | Process for the synthesis of nucleoside analogues |
Publications (3)
Publication Number | Publication Date |
---|---|
NO974512L NO974512L (no) | 1997-09-29 |
NO974512D0 NO974512D0 (no) | 1997-09-29 |
NO316174B1 true NO316174B1 (no) | 2003-12-22 |
Family
ID=10772237
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19974512A NO316174B1 (no) | 1995-03-31 | 1997-09-29 | Fremgangsmåte for syntese av nukleosid-analoger og mellomprodukter |
Country Status (17)
Country | Link |
---|---|
US (2) | US6143748A (ja) |
EP (1) | EP0817784B1 (ja) |
JP (1) | JP4173195B2 (ja) |
CN (2) | CN1995022B (ja) |
AT (1) | ATE241619T1 (ja) |
AU (1) | AU5497396A (ja) |
BR (2) | BRPI9607850B8 (ja) |
DE (1) | DE69628424T2 (ja) |
DK (1) | DK0817784T3 (ja) |
ES (1) | ES2200060T3 (ja) |
GB (1) | GB9506644D0 (ja) |
HK (1) | HK1009451A1 (ja) |
HU (1) | HU223100B1 (ja) |
NO (1) | NO316174B1 (ja) |
PL (1) | PL188693B1 (ja) |
PT (1) | PT817784E (ja) |
WO (1) | WO1996030369A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9506644D0 (en) * | 1995-03-31 | 1995-05-24 | Wellcome Found | Preparation of nucleoside analogues |
CA2714085C (en) | 1998-08-12 | 2013-02-05 | Emory University | Method of manufacture of 1,3-oxathiolane nucleosides |
US6979561B1 (en) | 1998-10-09 | 2005-12-27 | Gilead Sciences, Inc. | Non-homogeneous systems for the resolution of enantiomeric mixtures |
CN110156699A (zh) * | 2019-05-22 | 2019-08-23 | 南京合巨药业有限公司 | 一种4-乙氧基-1h-嘧啶-2-酮的制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
ZA923641B (en) * | 1991-05-21 | 1993-02-24 | Iaf Biochem Int | Processes for the diastereoselective synthesis of nucleosides |
GB9116601D0 (en) * | 1991-08-01 | 1991-09-18 | Iaf Biochem Int | 1,3-oxathiolane nucleoside analogues |
JP3499896B2 (ja) * | 1993-03-12 | 2004-02-23 | 財団法人野口研究所 | 2’−デオキシヌクレオシド類の製造方法 |
IL113432A (en) * | 1994-04-23 | 2000-11-21 | Glaxo Group Ltd | Process for the diastereoselective synthesis of nucleoside analogues |
GB9506644D0 (en) * | 1995-03-31 | 1995-05-24 | Wellcome Found | Preparation of nucleoside analogues |
-
1995
- 1995-03-31 GB GBGB9506644.5A patent/GB9506644D0/en active Pending
-
1996
- 1996-03-26 EP EP96911954A patent/EP0817784B1/en not_active Expired - Lifetime
- 1996-03-26 WO PCT/EP1996/001353 patent/WO1996030369A1/en active IP Right Grant
- 1996-03-26 AU AU54973/96A patent/AU5497396A/en not_active Abandoned
- 1996-03-26 US US08/930,224 patent/US6143748A/en not_active Expired - Lifetime
- 1996-03-26 ES ES96911954T patent/ES2200060T3/es not_active Expired - Lifetime
- 1996-03-26 PL PL96322503A patent/PL188693B1/pl unknown
- 1996-03-26 DK DK96911954T patent/DK0817784T3/da active
- 1996-03-26 BR BRPI9607850A patent/BRPI9607850B8/pt unknown
- 1996-03-26 CN CN200710001872XA patent/CN1995022B/zh not_active Expired - Lifetime
- 1996-03-26 AT AT96911954T patent/ATE241619T1/de active
- 1996-03-26 DE DE69628424T patent/DE69628424T2/de not_active Expired - Lifetime
- 1996-03-26 CN CNB961930160A patent/CN1290845C/zh not_active Expired - Lifetime
- 1996-03-26 BR BRPI9607850-2A patent/BR9607850B1/pt not_active IP Right Cessation
- 1996-03-26 HU HU9801576A patent/HU223100B1/hu active IP Right Grant
- 1996-03-26 PT PT96911954T patent/PT817784E/pt unknown
- 1996-03-26 JP JP52893296A patent/JP4173195B2/ja not_active Expired - Lifetime
-
1997
- 1997-09-29 NO NO19974512A patent/NO316174B1/no not_active IP Right Cessation
-
1998
- 1998-09-04 HK HK98110455A patent/HK1009451A1/xx not_active IP Right Cessation
-
1999
- 1999-06-28 US US09/340,123 patent/US6066733A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH11502826A (ja) | 1999-03-09 |
DE69628424D1 (de) | 2003-07-03 |
CN1995022B (zh) | 2013-01-02 |
JP4173195B2 (ja) | 2008-10-29 |
PT817784E (pt) | 2003-10-31 |
CN1290845C (zh) | 2006-12-20 |
ATE241619T1 (de) | 2003-06-15 |
GB9506644D0 (en) | 1995-05-24 |
HUP9801576A3 (en) | 2000-07-28 |
DE69628424T2 (de) | 2004-03-18 |
PL322503A1 (en) | 1998-02-02 |
BR9607850B1 (pt) | 2010-11-30 |
NO974512L (no) | 1997-09-29 |
BR9607850A (pt) | 1998-07-14 |
CN1180356A (zh) | 1998-04-29 |
HK1009451A1 (en) | 1999-09-10 |
US6143748A (en) | 2000-11-07 |
NO974512D0 (no) | 1997-09-29 |
US6066733A (en) | 2000-05-23 |
HU223100B1 (hu) | 2004-03-29 |
CN1995022A (zh) | 2007-07-11 |
EP0817784B1 (en) | 2003-05-28 |
HUP9801576A2 (hu) | 1999-05-28 |
PL188693B1 (pl) | 2005-03-31 |
WO1996030369A1 (en) | 1996-10-03 |
EP0817784A1 (en) | 1998-01-14 |
AU5497396A (en) | 1996-10-16 |
DK0817784T3 (da) | 2003-09-08 |
ES2200060T3 (es) | 2004-03-01 |
BRPI9607850B8 (pt) | 2019-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO300593B1 (no) | Fremgangsmåte ved diastereoselektiv syntese av nukleosider | |
US6329522B1 (en) | Process for the diastereoselective synthesis of nucleoside analogues | |
US20100249409A2 (en) | Process for stereoselective synthesis of lamivudine | |
EP0198348B1 (en) | Process for preparing (+)s-2-hydroxy-2-methyl-hexanoic acid | |
NO170933B (no) | Bicykliske aminokarboksylsyrer og fremgangsmaate til deresfremstilling | |
NO316174B1 (no) | Fremgangsmåte for syntese av nukleosid-analoger og mellomprodukter | |
CZ293942B6 (cs) | Způsob zvýšení výtěžku jednoho z enanciomerů alkoholů | |
NO338553B1 (no) | Prosess og fremgangsmåter for fremstilling av optisk aktiv CIS-2-hydroxymethyl-4-(cytosin-1'-YL)-1,3 oxathiolan eller farmasøytisk akseptable salter derav | |
US4668822A (en) | Method for preparing (+)S-2--hydroxy-2-methyl-hexanoic acid | |
US6380388B1 (en) | 1,3-oxathiolan-5-ones useful in the production of antiviral nucleoside analogues | |
JPH06279400A (ja) | 2−アミノエタノール誘導体の立体特異的製法 | |
KR20110081383A (ko) | 라미부딘의 제조방법 및 이에 사용되는 신규 중간체 | |
JPH0222272A (ja) | 光学活性化合物の製造法 | |
JPH0211566A (ja) | (−)−カイニン酸の中間体の合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |